Immunome selected as winner of annual New York Venture Summit Top Innovator award

Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.

“We are very excited and honored to be in this elite group of youngStartup Ventures Top Innovators”

As one of the winners, Tim Pelura, CEO of Immunome, will present the company at the exclusive 2010 New York Venture Summit on June 17^th at The Hotel Penn in New York City, where a select group of 450 entrepreneurs, investors, and corporate developers will gather to be the first to meet this next wave of leading edge companies.

"We are very excited and honored to be in this elite group of youngStartup Ventures Top Innovators," said Tim Pelura, president and CEO of Immunome. "Every day, physicians are seeing more and more patients with life threatening infections for which they have inadequate or no treatment options. We believe that if you want to cure a disease, you should start with the immune system of someone that has already done it. Our technology enables us to capture the natural curative antibodies of the healthy human immune system for use as therapies for those patients unable to mount a defense."

Honoring the Best

To Honor the youngStartup Ventures Top Innovator recipients, youngStartup Ventures has invited their CEOs and founders to present at The New York Venture Summit, a forum for the most exciting early stage and emerging growth companies, and to share their insights on the future of innovation, and the entrepreneurial journey. Held at The Hotel Penn in New York City, this intimate, invitation-only conference is the premier venue for today's promising startups.

SOURCE Immunome